Cargando…

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades

BACKGROUND: HIV-1 subtype B (HIV-1B) still dominates in resource-rich countries but increased migration contributes to changes in the global subtype distribution. Also, spread of non-B subtypes within such countries occurs. The trend of the subtype distribution from the beginning of the epidemic in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neogi, Ujjwal, Häggblom, Amanda, Santacatterina, Michele, Bratt, Göran, Gisslén, Magnus, Albert, Jan, Sonnerborg, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055746/ https://www.ncbi.nlm.nih.gov/pubmed/24922326 http://dx.doi.org/10.1371/journal.pone.0099390

Ejemplares similares

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
por: Neogi, Ujjwal, et al.
Publicado: (2017)

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
por: Häggblom, Amanda, et al.
Publicado: (2017)

Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997–2011
por: Bontell, Irene, et al.
Publicado: (2013)

HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries
por: Esbjörnsson, Joakim, et al.
Publicado: (2016)

HIV Care in the Swedish-Danish HIV Cohort 1995-2010, Closing the Gaps
por: Helleberg, Marie, et al.
Publicado: (2013)

Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003–2010
por: Karlsson, Annika, et al.
Publicado: (2012)

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
por: Rogers, Leonard, et al.
Publicado: (2018)

Emergence of unique recombinant forms (URFs) in Indian HIV-1 epidemic: data from nationwide clinical cohort between 2007 and 2011
por: Neogi, U, et al.
Publicado: (2012)

Molecular Epidemiology of HIV-1 Subtypes in India: Origin and Evolutionary History of the Predominant Subtype C
por: Neogi, Ujjwal, et al.
Publicado: (2012)

Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals
por: Neogi, Ujjwal, et al.
Publicado: (2013)

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
por: Elvstam, Olof, et al.
Publicado: (2020)

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
por: Zhang, Wang, et al.
Publicado: (2018)

The Swedish COVID-19 approach: a scientific dialogue on mitigation policies
por: Björkman, Anders, et al.
Publicado: (2023)

The expanding HIV-1 epidemic aggravates therapeutics and vaccine development programs in India
por: Neogi, Ujjwal
Publicado: (2009)

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014
por: Häggblom, Amanda, et al.
Publicado: (2017)

Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy
por: Bai, Xiangning, et al.
Publicado: (2021)

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
por: Singh, Kamalendra, et al.
Publicado: (2014)

Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy
por: Zhang, Wang, et al.
Publicado: (2017)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
por: Ray, Shilpa, et al.
Publicado: (2020)

Genetic analysis of HIV-1 Circulating Recombinant Form 02_AG, B and C subtype-specific envelope sequences from Northern India and their predicted co-receptor usage
por: Neogi, Ujjwal, et al.
Publicado: (2009)

Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
por: Sörstedt, Erik, et al.
Publicado: (2016)

Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
por: Saccon, Elisa, et al.
Publicado: (2021)

Plasma soluble factor following two decades prolonged suppressive antiretroviral therapy in HIV-1-positive males: A cross-sectional study
por: Sperk, Maike, et al.
Publicado: (2018)

Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management
por: Grossmann, Sebastian, et al.
Publicado: (2015)

Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy
por: Svärd, Jenny, et al.
Publicado: (2017)

Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden
por: de Coninck, Zaake, et al.
Publicado: (2018)

Spatio-temporal trends of PCBs in the Swedish freshwater environment 1981–2012
por: Nyberg, Elisabeth, et al.
Publicado: (2014)

43-Year Temporal Trends in Immune Response to Oral Bacteria in a Swedish Population
por: Esberg, Anders, et al.
Publicado: (2020)

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
por: Zhang, Wang, et al.
Publicado: (2017)

MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
por: Aralaguppe, Shambhu G., et al.
Publicado: (2019)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

P20-05. Emergence of HIV-1 circulatory recombinant forms (CRFs) and unique recombinant forms (URFs) in North India: functional and pathogenic implications
por: Neogi, U, et al.
Publicado: (2009)

Following the path: Increasing trends of HIV-1 drug resistance in China
por: Gupta, Soham, et al.
Publicado: (2020)

GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
por: Singh, Kamal, et al.
Publicado: (2019)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

Concentrations and temporal trends in pesticide biomarkers in urine of Swedish adolescents, 2000–2017
por: Norén, Erika, et al.
Publicado: (2020)

Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing
por: Telele, Nigus Fikrie, et al.
Publicado: (2018)

A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort
por: Telele, Nigus Fikrie, et al.
Publicado: (2019)

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers
por: Vesterbacka, Jan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cdmnr1r7lcp9ri87uedt2slp9b